Work

Abstract LB-B04: Development of a first-in-class leukemia inhibitory factor (LIF)/LIFR inhibitor, EC359 for targeted therapy

Year: 2018

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-17-lb-b04

Authors: Hareesh B. Nair, Bindu Santhamma, Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Xinlei Pan, Vijaya Manthati, Ratna K. Vadlamudi, Murali Ramachandran, Klaus J. Nickisch

Institutions: Evestra (United States), The University of Texas at San Antonio Health Science Center, Cedars-Sinai Medical Center

Language: English

Topic: Cytokine Signaling Pathways and Interactions

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2883920141

Cites:

Cited by:

Related to: 10